scholarly article | Q13442814 |
P50 | author | Eric Kossoff | Q90928928 |
Paula L. Pyzik | Q124281563 | ||
P2093 | author name string | James E Rubenstein | |
Amisha Patel | |||
Zahava Turner | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1277-1282 | |
P577 | publication date | 2010-02-01 | |
P1433 | published in | Epilepsia | Q5382969 |
P1476 | title | Long-term outcomes of children treated with the ketogenic diet in the past | |
P478 | volume | 51 |
Q92058778 | A Journey of Dietary Therapies for Epilepsy in Iran: Diet Restriction in the Ancient Era to the Ketogenic Diet in the Modern Period |
Q43098329 | An update on the ketogenic diet, 2012. |
Q43063864 | Anticonvulsant Effect of Time-Restricted Feeding in a Pilocarpine-Induced Seizure Model: Metabolic and Epigenetic Implications |
Q87636126 | Assessing parents' attitudes towards ketogenic dietary therapies |
Q47428484 | Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial |
Q91260473 | Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview |
Q91828414 | Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management |
Q30620281 | Danger in the pipeline for the ketogenic diet? |
Q37858251 | Dietary therapies for epilepsy: future research |
Q37868168 | Dietary treatments for epilepsy: management guidelines for the general practitioner |
Q89905987 | Effects of a ketogenic diet in overweight women with polycystic ovary syndrome |
Q36549674 | Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats |
Q38379396 | Epigenetic mechanisms in neurological and neurodegenerative diseases |
Q62868089 | Everolimus for epilepsy in paediatric tuberous sclerosis complex |
Q35853986 | Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids |
Q52656974 | Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned. |
Q34766019 | Ketogenic diet improves core symptoms of autism in BTBR mice |
Q38547606 | Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress |
Q33778181 | Ketogenic diet: Predictors of seizure control |
Q39164229 | Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse |
Q45824470 | Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? |
Q37807788 | Ketosis and the Ketogenic Diet, 2010: Advances in Treating Epilepsy and Other Disorders |
Q47855250 | Long-term follow-up of children treated with the modified Atkins diet |
Q27007233 | Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease |
Q99549278 | Nutrition, Bioenergetics, and Metabolic Syndrome |
Q38963725 | Nutritional interventions in primary mitochondrial disorders: Developing an evidence base. |
Q54918579 | Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. |
Q39675120 | Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures |
Q92999987 | Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet |
Q53801005 | Six-month efficacy of the Ketogenic diet is predicted after 3 months and is unrelated to clinical variables. |
Q58795119 | The Expanding Role of Ketogenic Diets in Adult Neurological Disorders |
Q33954540 | The effects of the ketogenic diet on behavior and cognition |
Q37861273 | The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus. |
Q38494270 | The ketogenic diet in pharmacoresistant childhood epilepsy |
Q42716720 | The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway |
Q41342600 | The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome |
Q38495538 | The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action |
Q35028378 | Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis |
Q39130869 | Treatment issues for children with epilepsy transitioning to adult care |
Search more.